Spectral Medical Inc's stock has seen a slight decline over the past week, reflecting broader market trends and company developments.
This week, Spectral Medical Inc (EDT.TO) closed at C$1.33, remaining stable on Wednesday with a 1D change of 0.00%. However, the stock has experienced a decline of 4.26% over the past week. The company's recent announcements and ongoing clinical trials continue to shape investor sentiment, even as trading volume remains notably low compared to its historical averages.
Investor takeaway: While Spectral Medical is making strides in its clinical trials and regulatory submissions, its stock performance remains subdued. Investors should consider the company's progress in securing FDA approval and the potential impact on future valuations.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$325.84M
52W high
$1.65
52W low
$1.03
1W change
-5.53%
Beta
0.22
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 183.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+183.8% Upside
Current Price
C$1.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
50.5%
Annualized
90-Day Vol
37.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.93
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.05 | C$0.88 – C$1.25 |
| 60 trading days | C$0.99 | C$0.77 – C$1.26 |
| 90 trading days | C$0.93 | C$0.69 – C$1.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Spectral Medical's stock has a 52-week range of C$1.21 to C$1.76.
Trading volume this week has been significantly lower than average, with only 220 shares traded compared to a 20-day average of 63,709 shares, indicating limited investor interest at this time.
Bull case
Positive developments in Spectral Medical's clinical trials and the recent FDA filing for its PMX therapy could lead to significant future growth. Analysts have set an average target price of C$3.15, suggesting a potential upside of 136.8%.
Bear case
The stock's current performance, showing a negative return year-to-date and low trading volume, may indicate challenges in gaining investor confidence. The lack of recent major news could further contribute to its stagnant price movement.
Recent Price Action
As of Wednesday, Spectral Medical Inc (EDT.TO) closed at C$1.33, unchanged from the previous day. Over the past week, the stock has seen a decline of 4.26%, reflecting market sentiment and possibly investor caution amid limited news flow.
Company Developments
Advertisement
Despite the lack of major news this week, Spectral Medical continues to make progress in its clinical trials and regulatory submissions. Notably, the company filed a Premarket Approval (PMA) application with the U.S. FDA for its PMX therapy, a significant milestone that could enhance its market position.
Technical Picture
The technical indicators show that the stock is currently trading below both its 50-day moving average of C$1.37 and its 200-day moving average of C$1.36, indicating a bearish trend. The 52-week trading range of C$1.21 to C$1.76 suggests that the stock is currently positioned in the lower end of this range, at approximately 22%. With a low beta of 0.21, the stock exhibits lower volatility compared to the market.
Volume and Market Sentiment
This week, trading volume for Spectral Medical has been significantly lower than usual, with only 220 shares traded compared to a 20-day average volume of 63,709 shares. This low trading activity may reflect a lack of investor interest or caution in the stock, which could affect future price movements.
Insider Activity
No recent insider activity has been reported for Spectral Medical, suggesting stability in the company's leadership and governance at this time.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
